New Zealand markets close in 2 hours 9 minutes

ResMed Inc. (RMD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
173.83-11.03 (-5.97%)
At close: 04:00PM EDT
175.00 +1.17 (+0.67%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close184.86
Bid174.00 x 800
Ask174.08 x 1000
Day's range172.19 - 183.40
52-week range132.24 - 243.52
Avg. volume1,030,470
Market cap25.568B
Beta (5Y monthly)0.67
PE ratio (TTM)28.78
EPS (TTM)6.04
Earnings date25 Apr 2024
Forward dividend & yield1.92 (1.04%)
Ex-dividend date07 Feb 2024
1y target est202.68
  • Investor's Business Daily

    Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test

    Eli Lilly stock popped Wednesday after the company's weight-loss drug significantly reduced nighttime sleep apnea events.

  • GlobeNewswire

    ResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024

    SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2024 on Thursday, April 25, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: • Location: • Da

  • Zacks

    5 Medical Product Stocks to Buy Amid Industry Challenges

    Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. SYK, RMD, ZBH, PODD and LNTH are well-poised to gain from the favorable factors.